Clinical Trial Update: Early Treatment of Acute Graft Versus Host Disease With Bone Marrow-Derived Mesenchymal Stem Cells and Corticosteroids [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial investigating early treatment of acute graft-versus-host disease with bone marrow-derived mesenchymal stem cells plus corticosteroids; study ter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Bone marrow-derived mesenchymal stem cells (bone marrow-derived mesenchymal stem cells)
• Corticosteroids (corticosteroids)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Graft-Versus-Host Disease | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2019-05-01